MarketPeel
Insider Trading Intelligence
PB

Philip P. Boudreau

ABT
VICE PRESIDENT · ABBOTT LABORATORIES · CIK 0001805099
FILING MIX · LIFETIME52%/48%
BUYS
16
SELLS
15
TOTAL VALUE
$7.06M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
9,276
AVG SELL PX
$113.46
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Philip P. Boudreau, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%-3.37%-2.51%-0.85%-2.17%
14d5+40.00%-2.61%+0.60%-3.21%-2.77%
30d5+40.00%-0.39%+2.61%-1.82%-2.61%
60d5+40.00%+3.75%+4.39%-0.63%-1.97%
90d5(1 pending)+75.00%-1.04%+4.21%-5.25%-5.07%
180d5(1 pending)+50.00%+1.86%+9.19%-7.33%-2.69%
1y5(2 pending)+66.67%+7.15%+19.89%-12.74%-7.10%
2y5(2 pending)+33.33%+15.72%+31.57%-15.85%-14.19%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABT · 9,276 shares · as of Apr 23, 2026
028,85357,70786,560115,413202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 15 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABT
ABBOTT LABORATORIES
PURCHASE
EVP AND CFO
2,200$91.50$201.3K2,200Apr 23, 2026Apr 27, 2026View →
ABT
ABBOTT LABORATORIES
PURCHASE
EVP AND CFO
8,909$92.04$820.0K9,276Apr 23, 2026Apr 27, 2026View →
ABT
ABBOTT LABORATORIES
SALE
EVP AND CFO
7,441$116.26$865.1K71,172Feb 27, 2026Mar 3, 2026View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
115,413115,413Feb 24, 2026Feb 26, 2026View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
27,99778,613Feb 24, 2026Feb 26, 2026View →
ABT
ABBOTT LABORATORIES
SALE
EVP AND CFO
387$132.66$51.3K50,616Sep 1, 2025Sep 3, 2025View →
ABT
ABBOTT LABORATORIES
SALE
EVP AND CFO
5,550$134.55$746.8K51,003Aug 8, 2025Aug 11, 2025View →
ABT
ABBOTT LABORATORIES
SALE
EVP AND CFO
4,908$135.87$666.8K56,553Feb 28, 2025Mar 4, 2025View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
83,78383,783Feb 25, 2025Feb 27, 2025View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
22,49561,461Feb 25, 2025Feb 27, 2025View →
ABT
ABBOTT LABORATORIES
SALE
EXECUTIVE VICE PRESIDENT
387$113.27$43.8K38,966Sep 1, 2024Sep 4, 2024View →
ABT
ABBOTT LABORATORIES
SALE
SENIOR VICE PRESIDENT
1,738$120.05$208.6K39,353Feb 29, 2024Mar 4, 2024View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
23,02441,091Feb 21, 2024Feb 23, 2024View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
86,51986,519Feb 21, 2024Feb 23, 2024View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
2,62018,067Sep 1, 2023Sep 6, 2023View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
10,22310,223Sep 1, 2023Sep 6, 2023View →
ABT
ABBOTT LABORATORIES
SALE10b5-1
10b5-1 plan
8,000$106.00$848.0K15,447Jun 16, 2023Jun 20, 2023View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
1,477$99.77$147.4K23,447Feb 28, 2023Mar 2, 2023View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
19,14919,149Feb 17, 2023Feb 22, 2023View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
4,85524,924Feb 17, 2023Feb 22, 2023View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
1,192$122.41$145.9K20,069Feb 28, 2022Mar 2, 2022View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
966$116.79$112.8K21,261Feb 22, 2022Feb 23, 2022View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
5,35122,227Feb 18, 2022Feb 23, 2022View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
24,93824,938Feb 18, 2022Feb 23, 2022View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
8,000$126.49$1.01M16,876Oct 25, 2021Oct 27, 2021View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
704$121.58$85.6K24,876Feb 26, 2021Mar 2, 2021View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
937$123.04$115.3K25,580Feb 22, 2021Feb 23, 2021View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
25,61325,613Feb 19, 2021Feb 23, 2021View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
4,99726,517Feb 19, 2021Feb 23, 2021View →
ABT
ABBOTT LABORATORIES
SALE
VICE PRESIDENT
943$128.23$120.9K21,520Feb 16, 2021Feb 18, 2021View →
ABT
ABBOTT LABORATORIES
SALE
Vice President
10,600$82.00$869.2K22,463Mar 13, 2020Mar 16, 2020View →
Other insiders · ABT
Loading peer insiders…
About this filer
CIK 0001805099
ROLE
VICE PRESIDENT
PRIMARY
ABT
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001805099DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback